The Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 has awarded an indefinite delivery contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide COVID-19 antigen testing supplies and services. The single-award contract has a ceiling value of $995,165.44 and runs through January 2026.
Under this contract, Abbott will deliver its BinaxNOW rapid COVID-19 antigen tests and related diagnostic materials to support coronavirus testing and screening efforts at VA facilities, primarily in Lockhart, Florida. The firm-fixed-price task orders issued to date range from $72,660.04 to $98,500.85, with completion dates through January 2027. This contract supports the VA's ongoing COVID-19 diagnostic needs and builds upon Abbott's existing Blanket Purchase Agreements with the agency to supply point-of-care testing equipment and reagents through its GSA Schedule 65-VII contract. The original solicitation did not utilize any set-aside designations.
Generated 1/28/25, 12:06 PM